|
2nd Generation SequencingOverview
Digital gene expression profiling with RNA-SeqMicroarrays are the state-of-the-art to measure gene expression, because they allow simultaneous measurement of a complete genome in one experiment. In this project, we have utilizied Illumina technology to sequence the poly adenylated fraction (RNA-Seq) of two cell lines. The short reads obtained can be used to infer gene expression levels, similar to gene microarrays, but avoiding biases introduced by hybridization methodologies. Using RNA-Seq we detect 25% more genes than microarrays. Moreover, we are able to find new transcription units and can also report splice variants of the transcripts expressed in the cell. This project is a collaboration with Marie-Laure Yaspo's Group at the Lehrach department . This work is published online at Science Express reported about by Genome Web News.Resequencing for disease gene identificationDue to the low costs of new sequencing technologies, resequencing of small target regions in disease patients can help elucidating the cause of genetic disorders. As a special case, patients with balanced translocations have been investigated and the disease chromosomes with the translocations have been sequenced using Illumina Solexa technology in Wei Chen's lab from the Ropers department . We contributed a novel algorithm to predict chromosomal breakpoints in patients with balanced translocations from short read data. Because of the high sequencing depths, the predictions where highly accurate and sufficiently close to find the exact chromosomal breakpoint positions by PCR amplification. The analysis of three patients lead to the identification of three new candidate genes for mental retardation (Chen et.al. [4]).Algorithms for short read handlingWe are investigating different strategies for short read assembly and matching using state-of-the-art string indices in cooperation with the group Algorithmic Bioinformatics lead by Prof. Knut Reinert at the Free University in Berlin.PeopleLiterature
ContactProf. Dr. Martin VingronGene Regulation Group Department Computational Molecular Biology Max Planck Institute for Molecular Genetics Ihnestrasse 73 14195 Berlin, Germany Tel: +49-30-8413-1150 FAX: +49-30-8413-1152 Last Change: 04 Jul 08/hk |